MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation Total Shareholders Equity 2011-2026 | CTSO
Annual Total Shareholders Equity Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.1 M | 23.5 M | 35.4 M | 62.6 M | 79.2 M | 3.42 M | 16.9 M | 10.3 M | 1.34 M | 9.85 M | 3.96 M | -14.3 M | -11.6 M | -10.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.2 M | -14.3 M | 15.8 M |
Quarterly Total Shareholders Equity Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.02 M | 11.6 M | 14.5 M | 11.1 M | 13.4 M | 17.4 M | 19.6 M | 23.3 M | 18.5 M | 24.1 M | 29 M | 35.4 M | 39.1 M | 47.6 M | 55.4 M | 62.6 M | 70.6 M | 74.4 M | 77.3 M | 79.2 M | 79.2 M | 79.2 M | 79.2 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 1.34 M | 1.34 M | -474 K | -474 K | 9.85 M | 8.21 M | 8.21 M | 8.21 M | 6.94 M | 3.96 M | 3.96 M | 3.96 M | -14.3 M | -14.3 M | -14.3 M | -14.3 M | -11.6 M | -11.6 M | -11.6 M | -11.6 M | -10.1 M | 318 K | 318 K | 318 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 79.2 M | -14.3 M | 17.6 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
12.4 M | $ 13.67 | -2.64 % | $ 2.05 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
198 M | $ 6.84 | 3.32 % | $ 491 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
25.4 M | $ 12.99 | -14.35 % | $ 351 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
129 M | $ 30.93 | -0.93 % | $ 1.42 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 4.58 | -0.22 % | $ 171 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-38.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
26.7 M | $ 3.4 | -0.58 % | $ 118 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 24.24 | 1.34 % | $ 205 M | USA |
 |
Bio-Rad Laboratories
BIO
|
6.57 B | $ 270.43 | 0.37 % | $ 7.63 B | USA |
 |
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.78 B | $ 39.96 | 0.18 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
24.2 B | $ 74.69 | 1.66 % | $ 111 B | USA |
 |
InMode Ltd.
INMD
|
683 M | $ 13.93 | -0.25 % | $ 900 M | Israel |
 |
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.46 | -2.67 % | $ 23.5 M | USA |
 |
IRadimed Corporation
IRMD
|
86.8 M | $ 100.47 | -0.03 % | $ 1.27 B | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 46.19 | 0.48 % | $ 1.43 B | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 70.29 | - | $ 3.83 B |  Britain |
 |
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M |  Canada |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
48 B | $ 96.28 | -0.39 % | $ 124 B | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 4.93 | -6.53 % | $ 729 M | USA |
 |
Delcath Systems
DCTH
|
68.7 M | $ 9.18 | -10.09 % | $ 262 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
189 M | $ 2.44 | -0.41 % | $ 143 M | Israel |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.1 M | $ 75.36 | -3.74 % | $ 2.12 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
1.52 B | $ 250.95 | 1.14 % | $ 17.7 B | USA |
 |
Quanterix Corporation
QTRX
|
347 M | $ 6.1 | -3.1 % | $ 229 M | USA |
 |
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
150 M | $ 18.54 | -0.22 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
8.77 M | $ 2.9 | - | $ 10.8 M | USA |